Alyeska Investment Group
CRL icon

Alyeska Investment Group’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$44.4M Buy
+292,712
New +$44.4M 0.16% 170
2025
Q1
Sell
-200,262
Closed -$37M 533
2024
Q4
$37M Buy
+200,262
New +$37M 0.14% 180
2022
Q4
Sell
-333,429
Closed -$65.6M 434
2022
Q3
$65.6M Buy
333,429
+90,737
+37% +$17.9M 0.77% 30
2022
Q2
$51.9M Buy
242,692
+126
+0.1% +$27K 0.59% 40
2022
Q1
$68.9M Buy
242,566
+52,319
+28% +$14.9M 0.76% 26
2021
Q4
$71.7M Buy
190,247
+79,335
+72% +$29.9M 0.83% 23
2021
Q3
$45.8M Buy
110,912
+49,937
+82% +$20.6M 0.57% 43
2021
Q2
$22.6M Buy
+60,975
New +$22.6M 0.26% 115
2020
Q3
Sell
-80,305
Closed -$14M 482
2020
Q2
$14M Buy
+80,305
New +$14M 0.21% 153
2020
Q1
Sell
-396,692
Closed -$60.6M 361
2019
Q4
$60.6M Buy
396,692
+157,716
+66% +$24.1M 0.8% 33
2019
Q3
$31.6M Buy
238,976
+93,093
+64% +$12.3M 0.46% 80
2019
Q2
$20.7M Buy
+145,883
New +$20.7M 0.27% 117
2018
Q4
Sell
-171,388
Closed -$23.1M 339
2018
Q3
$23.1M Sell
171,388
-328,488
-66% -$44.2M 0.25% 113
2018
Q2
$56.1M Sell
499,876
-117,928
-19% -$13.2M 0.5% 70
2018
Q1
$65.9M Buy
+617,804
New +$65.9M 0.55% 61
2017
Q3
Sell
-575,439
Closed -$58.2M 440
2017
Q2
$58.2M Sell
575,439
-171,037
-23% -$17.3M 0.49% 73
2017
Q1
$67.1M Sell
746,476
-99,848
-12% -$8.98M 0.55% 53
2016
Q4
$64.5M Buy
846,324
+254,519
+43% +$19.4M 0.53% 51
2016
Q3
$49.3M Sell
591,805
-2,624
-0.4% -$219K 0.46% 63
2016
Q2
$49M Buy
594,429
+18,194
+3% +$1.5M 0.46% 76
2016
Q1
$43.8M Buy
576,235
+543,253
+1,647% +$41.3M 0.4% 83
2015
Q4
$2.65M Buy
+32,982
New +$2.65M 0.03% 284
2014
Q2
Sell
-317,053
Closed -$19.1M 369
2014
Q1
$19.1M Sell
317,053
-32,947
-9% -$1.99M 0.52% 50
2013
Q4
$18.6M Buy
350,000
+50,000
+17% +$2.65M 0.73% 26
2013
Q3
$13.9M Buy
+300,000
New +$13.9M 0.57% 38